Open Access Review Article

Management Strategy Change of Endometrial Hyperplasia

Jiming Chen1*, Ruxia Shi11 and Jie Wu2

1Department of Obstetrics and Gynecology, the Affiliated Changzhou NO. 2 People’s Hospital of Nanjing Medical University, Changzhou 213000, Jiangsu Province, China

2Department of Obstetrics & Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China

Corresponding Author

Received Date: July 24, 2018;  Published Date: August 20, 2018


Endometrial hyperplasia refers to irregular proliferation of endometrial glands, combined with an increased proportion of gland and mesenchyme. This kind of disease generally results from reproductive endocrine disorder, which is closely related to long-term estrogen stimulation without progesterone antagonism. In recent years, the views on the treatment and management of endometrial hyperplasia have been updated and changed with the deepening of research. This paper mainly focuses on the following aspects: classification change of endometrial hyperplasia, indication change of diagnostic curettage, management change of endometrial hyperplasia.

Keywords: Endometrial hyperplasia; Diagnostic curettage; Levonorgestrel-releasing intrauterine system; Management strategy

Signup for Newsletter
Scroll to Top